| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | L-serine transmembrane transporter activity | 6.01e-05 | 9 | 182 | 3 | GO:0015194 | |
| GeneOntologyMolecularFunction | L-alanine transmembrane transporter activity | 6.01e-05 | 9 | 182 | 3 | GO:0015180 | |
| GeneOntologyMolecularFunction | isomerase activity | 6.89e-05 | 192 | 182 | 9 | GO:0016853 | |
| GeneOntologyMolecularFunction | GDP binding | 3.63e-04 | 103 | 182 | 6 | GO:0019003 | |
| GeneOntologyMolecularFunction | alanine transmembrane transporter activity | 3.82e-04 | 16 | 182 | 3 | GO:0022858 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 5.20e-04 | 41 | 182 | 4 | GO:0015175 | |
| GeneOntologyMolecularFunction | racemase and epimerase activity | 5.49e-04 | 18 | 182 | 3 | GO:0016854 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.49e-04 | 18 | 182 | 3 | GO:0008569 | |
| MousePheno | increased circulating LDL cholesterol level | 2.25e-07 | 80 | 154 | 9 | MP:0000182 | |
| MousePheno | abnormal circulating LDL cholesterol level | CT45A6 CT45A1 CT45A10 CT45A2 APOB CT45A7 WDR47 CT45A9 CT45A3 MTOR ALDH2 | 1.85e-06 | 163 | 154 | 11 | MP:0000181 |
| MousePheno | abnormal circulating non-HDL cholesterol level | CT45A6 CT45A1 CT45A10 CT45A2 APOB CT45A7 WDR47 CT45A9 CT45A3 MTOR ALDH2 | 4.84e-06 | 180 | 154 | 11 | MP:0020151 |
| Domain | INT_SG_DDX_CT_C | 4.55e-09 | 8 | 182 | 5 | PF15300 | |
| Domain | INT_SG_DDX_CT_C | 4.55e-09 | 8 | 182 | 5 | IPR029307 | |
| Domain | RmlC_Cupin | 1.45e-05 | 16 | 182 | 4 | IPR011051 | |
| Domain | L27_2 | 9.44e-05 | 2 | 182 | 2 | PF09045 | |
| Domain | L27_2 | 9.44e-05 | 2 | 182 | 2 | IPR015132 | |
| Domain | IPT | 1.28e-04 | 27 | 182 | 4 | SM00429 | |
| Domain | Grip | 1.42e-04 | 11 | 182 | 3 | SM00755 | |
| Domain | GRIP | 1.42e-04 | 11 | 182 | 3 | PF01465 | |
| Domain | Amidohydro-rel | 1.42e-04 | 11 | 182 | 3 | IPR006680 | |
| Domain | Spectrin_repeat | 1.71e-04 | 29 | 182 | 4 | IPR002017 | |
| Domain | Ran_BP1 | 1.88e-04 | 12 | 182 | 3 | PF00638 | |
| Domain | RANBD1 | 1.88e-04 | 12 | 182 | 3 | PS50196 | |
| Domain | GRIP_dom | 1.88e-04 | 12 | 182 | 3 | IPR000237 | |
| Domain | GRIP | 1.88e-04 | 12 | 182 | 3 | PS50913 | |
| Domain | TIG | 2.23e-04 | 31 | 182 | 4 | PF01833 | |
| Domain | RanBD | 2.42e-04 | 13 | 182 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 2.42e-04 | 13 | 182 | 3 | IPR000156 | |
| Domain | IPT | 2.53e-04 | 32 | 182 | 4 | IPR002909 | |
| Domain | SPEC | 2.53e-04 | 32 | 182 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.53e-04 | 32 | 182 | 4 | IPR018159 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.06e-04 | 14 | 182 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.06e-04 | 14 | 182 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.06e-04 | 14 | 182 | 3 | IPR013602 | |
| Domain | DHC_N2 | 3.06e-04 | 14 | 182 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.06e-04 | 14 | 182 | 3 | IPR011704 | |
| Domain | MT | 3.06e-04 | 14 | 182 | 3 | PF12777 | |
| Domain | AAA_8 | 3.06e-04 | 14 | 182 | 3 | PF12780 | |
| Domain | AAA_5 | 3.06e-04 | 14 | 182 | 3 | PF07728 | |
| Domain | DHC_fam | 3.80e-04 | 15 | 182 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 3.80e-04 | 15 | 182 | 3 | PF03028 | |
| Domain | PI3/4_kinase_CS | 3.80e-04 | 15 | 182 | 3 | IPR018936 | |
| Domain | Dynein_heavy_dom | 3.80e-04 | 15 | 182 | 3 | IPR004273 | |
| Domain | - | 4.64e-04 | 16 | 182 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 4.64e-04 | 16 | 182 | 3 | SM00146 | |
| Domain | TPR-like_helical_dom | 4.79e-04 | 233 | 182 | 9 | IPR011990 | |
| Domain | Ig_E-set | 5.43e-04 | 104 | 182 | 6 | IPR014756 | |
| Domain | TYR_PHOSPHATASE_PTP | 5.50e-04 | 39 | 182 | 4 | PS50055 | |
| Domain | G8_domain | 5.59e-04 | 4 | 182 | 2 | IPR019316 | |
| Domain | Retinoic_acid_rcpt | 5.59e-04 | 4 | 182 | 2 | IPR003078 | |
| Domain | G8 | 5.59e-04 | 4 | 182 | 2 | PS51484 | |
| Domain | G8 | 5.59e-04 | 4 | 182 | 2 | SM01225 | |
| Domain | G8 | 5.59e-04 | 4 | 182 | 2 | PF10162 | |
| Domain | PDZ | 6.27e-04 | 148 | 182 | 7 | SM00228 | |
| Domain | PTPase_domain | 6.67e-04 | 41 | 182 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 6.67e-04 | 41 | 182 | 4 | PF00102 | |
| Domain | PI3_PI4_kinase | 6.67e-04 | 18 | 182 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 6.67e-04 | 18 | 182 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 6.67e-04 | 18 | 182 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 6.67e-04 | 18 | 182 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 6.67e-04 | 18 | 182 | 3 | PS50290 | |
| Domain | - | 6.79e-04 | 150 | 182 | 7 | 2.30.42.10 | |
| Domain | PDZ | 7.06e-04 | 151 | 182 | 7 | PS50106 | |
| Domain | PDZ | 7.34e-04 | 152 | 182 | 7 | IPR001478 | |
| Domain | CPSASE_1 | 9.26e-04 | 5 | 182 | 2 | PS00866 | |
| Domain | FATC | 9.26e-04 | 5 | 182 | 2 | PF02260 | |
| Domain | - | 1.38e-03 | 6 | 182 | 2 | 3.90.1290.10 | |
| Domain | PbH1 | 1.38e-03 | 6 | 182 | 2 | SM00710 | |
| Domain | Hydantoinase/dihydroPyrase | 1.38e-03 | 6 | 182 | 2 | IPR011778 | |
| Domain | FAT | 1.38e-03 | 6 | 182 | 2 | PS51189 | |
| Domain | FATC | 1.38e-03 | 6 | 182 | 2 | PS51190 | |
| Domain | CPSASE_2 | 1.38e-03 | 6 | 182 | 2 | PS00867 | |
| Domain | FAT | 1.38e-03 | 6 | 182 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.38e-03 | 6 | 182 | 2 | IPR003151 | |
| Domain | FATC_dom | 1.38e-03 | 6 | 182 | 2 | IPR003152 | |
| Domain | PbH1 | 1.38e-03 | 6 | 182 | 2 | IPR006626 | |
| Domain | PIK_FAT | 1.38e-03 | 6 | 182 | 2 | IPR014009 | |
| Domain | FATC | 1.38e-03 | 6 | 182 | 2 | SM01343 | |
| Domain | ACTININ_2 | 1.40e-03 | 23 | 182 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.40e-03 | 23 | 182 | 3 | PS00019 | |
| Domain | - | 1.40e-03 | 23 | 182 | 3 | 3.40.50.10190 | |
| Domain | Actinin_actin-bd_CS | 1.40e-03 | 23 | 182 | 3 | IPR001589 | |
| Domain | Metal_Hydrolase | 1.58e-03 | 24 | 182 | 3 | IPR032466 | |
| Domain | NA_DICARBOXYL_SYMP_1 | 1.92e-03 | 7 | 182 | 2 | PS00713 | |
| Domain | NA_DICARBOXYL_SYMP_2 | 1.92e-03 | 7 | 182 | 2 | PS00714 | |
| Domain | Plectin | 1.92e-03 | 7 | 182 | 2 | PF00681 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 1.92e-03 | 7 | 182 | 2 | IPR005479 | |
| Domain | BC-like_N | 1.92e-03 | 7 | 182 | 2 | IPR005481 | |
| Domain | Rab_bind | 1.92e-03 | 7 | 182 | 2 | PF16704 | |
| Domain | SDF | 1.92e-03 | 7 | 182 | 2 | PF00375 | |
| Domain | - | 1.92e-03 | 7 | 182 | 2 | 1.10.3860.10 | |
| Domain | Plectin_repeat | 1.92e-03 | 7 | 182 | 2 | IPR001101 | |
| Domain | GCC2_Rab_bind | 1.92e-03 | 7 | 182 | 2 | IPR032023 | |
| Domain | Na-dicarboxylate_symporter | 1.92e-03 | 7 | 182 | 2 | IPR001991 | |
| Domain | CPSase_L_D2 | 1.92e-03 | 7 | 182 | 2 | PF02786 | |
| Domain | Na-dicarboxylate_symporter_CS | 1.92e-03 | 7 | 182 | 2 | IPR018107 | |
| Domain | Biotin_carb_N | 1.92e-03 | 7 | 182 | 2 | PF00289 | |
| Domain | PLEC | 1.92e-03 | 7 | 182 | 2 | SM00250 | |
| Domain | BRCT | 2.01e-03 | 26 | 182 | 3 | PS50172 | |
| Domain | BRCT_dom | 2.49e-03 | 28 | 182 | 3 | IPR001357 | |
| Domain | Gprotein_alpha_I | 2.54e-03 | 8 | 182 | 2 | IPR001408 | |
| Domain | Pectin_lyase_fold/virulence | 2.54e-03 | 8 | 182 | 2 | IPR011050 | |
| Domain | - | 2.54e-03 | 8 | 182 | 2 | 2.30.40.10 | |
| Domain | PDZ | 2.61e-03 | 141 | 182 | 6 | PF00595 | |
| Domain | PTPc_motif | 2.62e-03 | 59 | 182 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 2.62e-03 | 59 | 182 | 4 | IPR003595 | |
| Domain | VWF_A | 2.84e-03 | 99 | 182 | 5 | IPR002035 | |
| Domain | Plexin_cytopl | 3.25e-03 | 9 | 182 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 3.25e-03 | 9 | 182 | 2 | IPR013548 | |
| Domain | Plexin | 3.25e-03 | 9 | 182 | 2 | IPR031148 | |
| Domain | TPR-contain_dom | 3.55e-03 | 150 | 182 | 6 | IPR013026 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.20e-05 | 15 | 141 | 4 | MM15031 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.59e-05 | 16 | 141 | 4 | M8245 | |
| Pathway | KEGG_PROPANOATE_METABOLISM | 1.77e-05 | 33 | 141 | 5 | M4086 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 4.19e-05 | 64 | 141 | 6 | M7923 | |
| Pubmed | Identification of cancer/testis-antigen genes by massively parallel signature sequencing. | CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 CT45A3 CT45A5 | 1.66e-17 | 15 | 189 | 9 | 15905330 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNC ACACA DSP LARS1 DDX56 NHP2 SLC1A5 AAR2 WDR47 SFXN1 BLVRA PARP1 POLR3B NOP14 MTHFD1 AHNAK MDC1 INTS11 MIB1 GEMIN4 PDCD11 PRPF19 PLEC ASCC3 PPIH CTSD GCN1 MVP UTRN PTCD3 | 6.16e-11 | 1353 | 189 | 30 | 29467282 |
| Pubmed | FLNC ACACA CENPF DSP DDX56 NOP14 ANAPC1 MTOR AHNAK MDC1 GEMIN4 PDCD11 PLEC ASCC3 GCN1 MVP HSPA2 UTRN CNOT1 STAG2 PTCD3 | 8.46e-11 | 653 | 189 | 21 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ACACA ATR CENPF DSP DYNC2H1 LARS1 DDX56 APOB NHP2 SLC1A5 SFXN1 PARP1 ANAPC1 MTHFD1 MTOR TBK1 MDC1 CSRP2 INTS11 GEMIN4 PDCD11 PRPF19 ALDH2 ATP1B3 CTSD GCN1 CNOT1 STAG2 PLXNA1 PTCD3 | 2.13e-10 | 1425 | 189 | 30 | 30948266 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNC ACACA DSP DYNC2H1 SPTA1 LARS1 SLC1A5 RYR1 DNAH1 SFXN1 PARP1 MTHFD1 SCD AHNAK PRPF19 PLEC CTSD GCN1 HSPA2 UTRN CNOT1 RIC3 | 6.57e-10 | 807 | 189 | 22 | 30575818 |
| Pubmed | PPAN ACADM TTI2 LARS1 DDX56 SLC1A5 PDCD4 TRAPPC1 BLVRA LIFR PARP1 POLR3B MTOR AHNAK MDC1 CSRP2 GEMIN4 PDCD11 PRPF19 OS9 ALDH2 ASCC3 ATP1B3 GCN1 HSPA2 CNOT1 STAG2 FKBP5 PTCD3 | 1.22e-09 | 1440 | 189 | 29 | 30833792 | |
| Pubmed | PLXNA3 FLNC PPAN RGPD8 CENPF DSP SPTA1 ITSN1 EML6 RGPD1 ANKRD30B APOB SLC30A2 AAR2 PARP1 NOP14 AHNAK PKHD1 PRPF19 UGGT2 MYOM2 GNAI3 ALDH2 PLEC HSPA2 PREX1 STAG2 GOLGB1 RGPD5 | 1.26e-09 | 1442 | 189 | 29 | 35575683 | |
| Pubmed | ACACA RGPD8 CENPF DSP RGPD1 ZFHX4 ANAPC1 AHNAK TBK1 GEMIN4 PLEC ASCC3 GCN1 UTRN CNOT1 GOLGB1 | 1.42e-09 | 418 | 189 | 16 | 34709266 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PPAN CENPF DSP LARS1 DDX56 GPKOW PDCD4 AAR2 SFXN1 PARP1 PTPN3 NOP14 FAM83F MTHFD1 AHNAK MDC1 GEMIN4 PDCD11 PRPF19 GNAI3 PLEC ASCC3 PATJ CTSD MVP PTCD3 | 5.60e-09 | 1257 | 189 | 26 | 36526897 |
| Pubmed | MED14 DDX56 ITGA1 SLC1A4 SLC1A5 PARP1 EHBP1L1 NOP14 PTPRC MTHFD1 MTOR SCD NBEAL2 AHNAK GEMIN4 PRPF19 GNAI3 ASCC3 GCN1 MVP HSPA2 CNOT1 STAG2 FKBP5 GOLGB1 | 5.76e-09 | 1168 | 189 | 25 | 19946888 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | VPS37C HSPG2 PSAP DSP DYNC2H1 ITGA1 ITIH4 RYR1 BLVRA MTHFD1 ASAH1 NAPRT AHNAK PKHD1 GEMIN4 GNAI3 ALDH2 PATJ CTSD MVP HSPA2 UTRN FKBP5 | 8.83e-09 | 1016 | 189 | 23 | 19056867 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLXNA3 HSPG2 FLNC CRYBG2 DIRAS1 ACACA INPPL1 MED14 DDX56 SLC1A5 RYR1 EHBP1L1 FAM83F MTOR NAPRT NBEAL2 AHNAK INTS11 PDCD11 POLL PLEC GCN1 PREX1 PLXNA1 | 9.04e-09 | 1105 | 189 | 24 | 35748872 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PPAN ACACA ACADM ACSS1 LARS1 DDX56 NHP2 SLC1A5 PDCD4 ITIH4 SFXN1 BLVRA PARP1 NOP14 MTHFD1 SCD AHNAK MIB1 PDCD11 PRPF19 CDK11B PLEC ASCC3 GCN1 FKBP5 PTCD3 | 1.46e-08 | 1318 | 189 | 26 | 30463901 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | ACACA ATR DSP CNTNAP1 ANAPC1 MTOR AHNAK PLEC ASCC3 GCN1 CNOT1 | 1.61e-08 | 202 | 189 | 11 | 33005030 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | VPS37C RGPD8 CENPF RGPD1 CPS1 PCMTD1 NHP2 GPKOW AAR2 FBXO38 ANAPC1 ASAH1 AHNAK MIB1 GNAT3 PRPF19 GNAI3 PPIH GCN1 CNOT1 STAG2 RGPD5 KIF1C PTCD3 | 2.09e-08 | 1155 | 189 | 24 | 20360068 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | ACACA RGPD8 ACADM DSP LARS1 RGPD1 SLC1A5 GGCX TRAPPC1 AAR2 SFXN1 PARP1 ANAPC1 MTHFD1 SCD GEMIN4 PRPF19 GNAI3 ASCC3 PPIH GCN1 HSPA2 CNOT1 FKBP5 RGPD5 | 2.43e-08 | 1257 | 189 | 25 | 37317656 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DNAH3 ACACA CENPF DSP ITSN1 TTI2 CT45A2 MAGEE2 RYR1 CT45A9 SFXN1 CT45A8 MTHFD1 AHNAK TBK1 PKHD1 GNAT3 UTRN CNOT1 | 2.45e-08 | 736 | 189 | 19 | 29676528 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNC PPAN CENPF DSP LARS1 DDX56 SLC1A5 SFXN1 PARP1 MTHFD1 AHNAK TBK1 MDC1 PDCD11 PRPF19 PLEC ASCC3 GCN1 UTRN CNOT1 STAG2 GOLGB1 | 4.77e-08 | 1024 | 189 | 22 | 24711643 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | FLNC ACACA ATR DSP LARS1 SLC1A5 PARP1 MTHFD1 AHNAK PLEC CTSD GCN1 HSPA2 KIF1C PTCD3 | 6.31e-08 | 477 | 189 | 15 | 31300519 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | ACACA CENPF LARS1 MED14 CPS1 SFXN1 BLVRA POLR3B MTOR FDXR INTS11 PDCD11 GNAI3 ASCC3 GCN1 CNOT1 FKBP5 CDK6 | 6.74e-08 | 704 | 189 | 18 | 29955894 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | FLNC PPAN ACADM DYNC2H1 MPDZ NHP2 SLC1A5 PDCD4 FBXO38 PARP1 POLR3B TBK1 UGGT2 PLEC ASCC3 PPIH GCN1 UTRN CNOT1 FKBP5 RGPD5 | 1.56e-07 | 1005 | 189 | 21 | 19615732 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | FRMPD4 DSP LARS1 DDX56 APOB CPS1 PDCD4 PARP1 MTHFD1 AHNAK TBK1 MDC1 GEMIN4 PDCD11 PRPF19 GNAI3 CDK11B PLEC MVP HSPA2 | 2.75e-07 | 949 | 189 | 20 | 36574265 |
| Pubmed | DSP LARS1 SLC1A5 SFXN1 PARP1 MTHFD1 MDC1 PDCD11 GNAI3 CDK11B ATP1B3 CTSD GCN1 STAG2 | 2.83e-07 | 463 | 189 | 14 | 34901782 | |
| Pubmed | FLNC DMXL2 DSP SPTA1 ITSN1 CNTNAP1 RBP3 DPYSL5 LARS1 SLC1A4 TRAPPC1 CRMP1 WDR47 PARP1 CPNE6 CORO2B MTHFD1 PRPF19 ALDH2 PLEC HSPA2 UTRN CNOT1 DIRAS2 PTCD3 | 2.85e-07 | 1431 | 189 | 25 | 37142655 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FLNC PSAP ACACA DSP LARS1 MPDZ PARP1 MTHFD1 AHNAK CSRP2 GEMIN4 PRPF19 PLEC ASCC3 PATJ PPIH CTSD GCN1 HSPA2 CNOT1 FKBP5 PTCD3 | 3.43e-07 | 1149 | 189 | 22 | 35446349 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | VPS37C FLNC DMXL2 DSP DPYSL5 MED14 DDX56 CRMP1 SFXN1 PARP1 EHBP1L1 NOP14 INTS11 PRPF19 CDK11B PLEC PPIH GCN1 MVP CNOT1 PTCD3 | 5.20e-07 | 1082 | 189 | 21 | 38697112 |
| Pubmed | FLNC LARS1 GPAT3 THTPA SRR CPS1 NHP2 SLC1A5 GGCX AAR2 SFXN1 PARP1 NOP14 MTHFD1 ATP1B3 GCN1 PREX1 | 5.30e-07 | 725 | 189 | 17 | 27025967 | |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 6.14e-07 | 231 | 189 | 10 | 36597993 | |
| Pubmed | 6.29e-07 | 4 | 189 | 3 | 14691372 | ||
| Pubmed | HSPG2 FLNC DMXL2 PSAP DSP SGCG ZNF407 RYR1 TBK1 OS9 MYOM2 PLEC UTRN STAG2 | 6.58e-07 | 497 | 189 | 14 | 23414517 | |
| Pubmed | 6.90e-07 | 234 | 189 | 10 | 36243803 | ||
| Pubmed | 7.87e-07 | 183 | 189 | 9 | 23956138 | ||
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 8.07e-07 | 298 | 189 | 11 | 32353859 | |
| Pubmed | VPS37C DMXL2 DIRAS1 FRMPD4 ACACA RGPD8 ACADM DSP CNTNAP1 RGPD1 SLC1A4 WDR47 SFXN1 MTHFD1 SCD PLEC GCN1 HSPA2 CNOT1 DIRAS2 PTCD3 | 1.18e-06 | 1139 | 189 | 21 | 36417873 | |
| Pubmed | HSPG2 PSAP ACACA CNTNAP1 CPS1 GGCX LIFR PTPRC MTHFD1 ASAH1 OS9 UGGT2 CTSD GCN1 PLXNA1 | 1.50e-06 | 613 | 189 | 15 | 22268729 | |
| Pubmed | IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation. | 1.57e-06 | 5 | 189 | 3 | 21464307 | |
| Pubmed | A contextual model for axonal sorting into glomeruli in the mouse olfactory system. | 1.57e-06 | 5 | 189 | 3 | 15186781 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FLNC PSAP ACACA DSP CT45A2 NHP2 GPKOW SLC1A4 SFXN1 BLVRA PARP1 ASAH1 MTOR AHNAK CSRP2 PDCD11 GNAI3 ATP1B3 GCN1 MVP UTRN CNOT1 GOLGB1 | 1.68e-06 | 1367 | 189 | 23 | 32687490 |
| Pubmed | DSP DDX56 APOB NHP2 GPKOW SLC1A5 GGCX PARP1 AHNAK TBK1 INTS11 GEMIN4 PDCD11 PRPF19 GNAI3 CDK11B PLEC ASCC3 PPIH GCN1 CNOT1 DIRAS2 PTCD3 | 1.76e-06 | 1371 | 189 | 23 | 36244648 | |
| Pubmed | DMXL2 DYNC2H1 ITSN1 GPAT3 MPDZ SLC1A5 AAR2 LIFR PARP1 NOP14 SCD MIB1 PDCD11 PRPF19 OS9 UGGT2 ALDH2 DDHD2 ASCC3 ATP1B3 HSPA2 FKBP5 GOLGB1 PTCD3 | 2.01e-06 | 1487 | 189 | 24 | 33957083 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | FLNC ACACA CENPF DSP DDX56 SLC1A5 SFXN1 PARP1 NOP14 CT45A3 MTHFD1 AHNAK MDC1 FDXR PDCD11 PRPF19 CDK11B PLEC PTCD3 | 2.17e-06 | 989 | 189 | 19 | 36424410 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | LARS1 PDCD4 FBXO38 PARP1 ANAPC1 MTHFD1 AHNAK MDC1 PLEC GCN1 STAG2 | 2.30e-06 | 332 | 189 | 11 | 32786267 |
| Pubmed | FLNC PSAP DSP LARS1 PARP1 INTS14 ANAPC1 MTHFD1 AHNAK TBK1 GEMIN4 PRPF19 PLEC ASCC3 GCN1 CNOT1 PTCD3 | 2.34e-06 | 809 | 189 | 17 | 32129710 | |
| Pubmed | ACACA ACADM LARS1 PARP1 MTHFD1 MTOR GEMIN4 PDCD11 PRPF19 PLEC ASCC3 GCN1 HSPA2 CNOT1 STAG2 | 2.45e-06 | 638 | 189 | 15 | 33239621 | |
| Pubmed | ACACA DSP CNTNAP1 LARS1 APOB SLC1A5 BLVRA PARP1 MTHFD1 NAPRT AHNAK TBK1 MDC1 CSRP2 PDCD11 PRPF19 OS9 UGGT2 GNAI3 CTSD CNOT1 CDK6 | 2.52e-06 | 1297 | 189 | 22 | 33545068 | |
| Pubmed | FLNC ACACA SLC1A4 SFXN1 PARP1 PDCD11 PRPF19 GNAI3 ASCC3 ATP1B3 CTSD CNOT1 GOLGB1 | 2.81e-06 | 484 | 189 | 13 | 31995728 | |
| Pubmed | RGPD8 ITSN1 GPAT3 MPDZ GPKOW GGCX POLR3B ANAPC1 SCD MDC1 CSRP2 OS9 UGGT2 CDK11B PATJ FKBP5 | 2.91e-06 | 733 | 189 | 16 | 34672954 | |
| Pubmed | 2.98e-06 | 215 | 189 | 9 | 35973513 | ||
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | LARS1 MPDZ NHP2 SLC1A5 SFXN1 ANAPC1 MTHFD1 SCD OS9 PATJ ATP1B3 CTSD GCN1 RGPD5 | 3.32e-06 | 571 | 189 | 14 | 37167062 |
| Pubmed | HSPG2 FLNC RGPD8 DSP RGPD1 SLC1A5 CPNE6 MTHFD1 AHNAK TBK1 CSRP2 PLEC GCN1 MVP HSPA2 UTRN RGPD5 | 4.11e-06 | 844 | 189 | 17 | 25963833 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ATR DSP MAGEE2 PARP1 ANAPC1 AHNAK GEMIN4 PRPF19 PLEC GCN1 MVP CNOT1 STAG2 GOLGB1 | 4.13e-06 | 582 | 189 | 14 | 20467437 |
| Pubmed | ACACA DSP DYNC2H1 LARS1 MED14 APOB C1orf167 ITIH4 CRMP1 PARP1 RGS6 SCD MDC1 PPIH CTSD GOLGB1 | 4.15e-06 | 754 | 189 | 16 | 35906200 | |
| Pubmed | 4.34e-06 | 169 | 189 | 8 | 31462741 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | DMXL2 CT45A6 CT45A1 CYP3A43 CT45A10 LARS1 ARHGEF38 CT45A2 NHP2 SLC1A4 CT45A7 WDR47 CT45A9 EHBP1L1 CT45A3 MTOR NBEAL2 EPC1 OS9 ALDH2 DSCC1 | 4.55e-06 | 1242 | 189 | 21 | 30973865 |
| Pubmed | DSP SLC1A5 PTP4A1 FBXO38 PARP1 PTPN3 NOP14 PTPRC PTPRE C1orf226 AHNAK INTS11 MIB1 PRPF19 GCN1 HSPA2 UTRN CNOT1 FKBP5 | 5.06e-06 | 1049 | 189 | 19 | 27880917 | |
| Pubmed | Arf4 is required for Mammalian development but dispensable for ciliary assembly. | 5.44e-06 | 7 | 189 | 3 | 24586199 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 5.44e-06 | 7 | 189 | 3 | 15710750 | |
| Pubmed | FLNC ACACA LARS1 SFXN1 PARP1 MTOR TBK1 GEMIN4 ALDH2 GCN1 UTRN FKBP5 | 5.47e-06 | 437 | 189 | 12 | 20562859 | |
| Pubmed | TTI2 SLC1A5 AAR2 PARP1 POLR3B MTHFD1 ASAH1 GEMIN4 PRPF19 KIF1C | 6.35e-06 | 300 | 189 | 10 | 28561026 | |
| Pubmed | 6.57e-06 | 237 | 189 | 9 | 29564676 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ACACA PDE9A DPYSL5 ARHGEF38 WDR27 DDX56 ANKMY1 DNAH1 SFXN1 ZNF33A PTPRE TBK1 ACSF3 RASEF OS9 PNPLA7 PATJ UTRN CNOT1 STAG2 FKBP5 GOLGB1 PDZD2 | 6.86e-06 | 1489 | 189 | 23 | 28611215 |
| Pubmed | 6.90e-06 | 23 | 189 | 4 | 15766748 | ||
| Pubmed | Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAP. | 6.90e-06 | 23 | 189 | 4 | 26933062 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PPAN ACACA DSP LARS1 DDX56 SLC1A5 PDCD4 PTP4A1 SFXN1 PTPN3 IKBKE MTHFD1 GEMIN4 PRPF19 CDK11B ATP1B3 GCN1 CNOT1 PREX1 CDK6 PTCD3 | 7.54e-06 | 1284 | 189 | 21 | 17353931 |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | PPAN RGPD8 LARS1 RGPD1 DDX56 NHP2 GPKOW SFXN1 PTPRC TBK1 GNAI3 ALDH2 PLEC ASCC3 GCN1 | 7.59e-06 | 701 | 189 | 15 | 30196744 |
| Pubmed | DMXL2 RARB PSAP PDE9A DSP ITSN1 CNTNAP1 LARS1 NHP2 TRAPPC1 CRMP1 WDR47 PARP1 CORO2B POLR3B MIB1 PLEC MVP HSPA2 UTRN PREX1 | 7.63e-06 | 1285 | 189 | 21 | 35914814 | |
| Pubmed | HSPG2 FLNC ACACA INPPL1 LARS1 NHP2 PARP1 MTHFD1 AHNAK PRPF19 GNAI3 PLEC PPIH GCN1 CNOT1 | 8.40e-06 | 707 | 189 | 15 | 19738201 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | SPTA1 CNTNAP1 SLC1A4 TRIM23 CRMP1 SFXN1 CPNE6 PTPRE MTHFD1 MTOR GNAI3 ALDH2 MVP HSPA2 | 8.61e-06 | 621 | 189 | 14 | 22794259 |
| Pubmed | SAGE2Splice: unmapped SAGE tags reveal novel splice junctions. | 8.67e-06 | 8 | 189 | 3 | 16683015 | |
| Pubmed | 8.67e-06 | 8 | 189 | 3 | 20810650 | ||
| Pubmed | 8.94e-06 | 312 | 189 | 10 | 37120454 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | FLNC DSP CNTNAP1 GPAT3 ZNF407 SLC1A4 SLC1A5 GGCX AAR2 PARP1 NOP14 ANAPC1 SCD AHNAK GEMIN4 GNAI3 PLEC ATP1B3 CNOT1 GOLGB1 | 9.95e-06 | 1203 | 189 | 20 | 29180619 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ACACA DSP LARS1 CPS1 NHP2 PDCD4 AAR2 PARP1 MTHFD1 AHNAK MDC1 CSRP2 GEMIN4 PRPF19 PLEC PPIH CTSD GCN1 STAG2 GOLGB1 KIF1C PTCD3 | 9.97e-06 | 1415 | 189 | 22 | 28515276 |
| Pubmed | 1.01e-05 | 250 | 189 | 9 | 18660489 | ||
| Pubmed | TTI2 RGPD1 PARP1 POLR3B ANAPC1 CDK11B PPIH GCN1 HSPA2 CNOT1 FKBP5 | 1.06e-05 | 390 | 189 | 11 | 17643375 | |
| Pubmed | ACACA DSP MED14 MPDZ ANAPC1 AHNAK MDC1 PDCD11 ASCC3 PATJ GCN1 CNOT1 RGPD5 | 1.09e-05 | 549 | 189 | 13 | 38280479 | |
| Pubmed | DSP LARS1 SFXN1 PARP1 NOP14 MTHFD1 CSRP2 PDCD11 PRPF19 GNAI3 GCN1 CNOT1 DIRAS2 CDK6 | 1.23e-05 | 641 | 189 | 14 | 36057605 | |
| Pubmed | Genomic analysis of orthologous mouse and human olfactory receptor loci. | 1.30e-05 | 9 | 189 | 3 | 11416212 | |
| Pubmed | 1.33e-05 | 197 | 189 | 8 | 31620119 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | HSPG2 FLNC PSAP ACACA ACADM DSP CNTNAP1 ITGA1 GGCX SFXN1 BLVRA PTPRC SCD AHNAK FDXR UGGT2 CDK11B ALDH2 PNPLA7 PLEC PLXNA1 PTCD3 | 1.47e-05 | 1451 | 189 | 22 | 30550785 |
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 1.77e-05 | 59 | 189 | 5 | 28813667 | |
| Pubmed | TopBP1 controls BLM protein level to maintain genome stability. | 1.80e-05 | 29 | 189 | 4 | 24239288 | |
| Pubmed | FLNC CENPF DSP LARS1 PARP1 MTHFD1 AHNAK PRPF19 PLEC GCN1 MVP CNOT1 | 1.86e-05 | 494 | 189 | 12 | 26831064 | |
| Pubmed | 1.97e-05 | 208 | 189 | 8 | 11790298 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | PSAP DYNC2H1 GPKOW SLC1A5 NOP14 ANAPC1 MTOR MDC1 CSRP2 GEMIN4 PDCD11 PPIH ATP1B3 CTSD | 2.00e-05 | 670 | 189 | 14 | 22990118 |
| Pubmed | DMXL2 RGPD8 CENPF ITSN1 CNTNAP1 RGPD1 MPDZ ITIH4 CRMP1 WDR47 PARP1 RGS6 ANAPC1 MTOR TBK1 CNOT1 GOLGB1 | 2.25e-05 | 963 | 189 | 17 | 28671696 | |
| Pubmed | PPAN MED14 MPDZ DDX56 NHP2 GGCX NOP14 ANAPC1 MTHFD1 SCD MDC1 INTS11 GEMIN4 PDCD11 OS9 ASCC3 PATJ UTRN PREX1 STAG2 GOLGB1 PTCD3 | 2.36e-05 | 1497 | 189 | 22 | 31527615 | |
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | ATR INPPL1 PARP1 SERPINI2 RGS6 PIK3CA MTHFD1 MTOR ASCC3 CDK6 | 2.46e-05 | 351 | 189 | 10 | 20453000 |
| Pubmed | PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator. | 2.52e-05 | 11 | 189 | 3 | 15808511 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FLNC DPYSL5 MPDZ SLC1A5 PTP4A1 AAR2 PTPN3 MTOR GEMIN4 PRMT9 OS9 GNAI3 ASCC3 GCN1 UTRN FKBP5 PTCD3 | 2.60e-05 | 974 | 189 | 17 | 28675297 |
| Pubmed | 2.84e-05 | 285 | 189 | 9 | 32838362 | ||
| Pubmed | PSAP ITSN1 ANGEL1 APOB CRMP1 INTS14 PTPRC MTHFD1 SCD RPEL1 GNAI3 PLEC PATJ UTRN CNOT1 STAG2 GOLGB1 CDK6 | 2.87e-05 | 1084 | 189 | 18 | 11544199 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 27189717 | ||
| Pubmed | Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer. | 2.94e-05 | 2 | 189 | 2 | 27055253 | |
| Pubmed | SHIP2 associates with intersectin and recruits it to the plasma membrane in response to EGF. | 2.94e-05 | 2 | 189 | 2 | 18692052 | |
| Pubmed | PARP-1 modulation of mTOR signaling in response to a DNA alkylating agent. | 2.94e-05 | 2 | 189 | 2 | 23110147 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 10403379 | ||
| Pubmed | mTOR may interact with PARP-1 to regulate visible light-induced parthanatos in photoreceptors. | 2.94e-05 | 2 | 189 | 2 | 32066462 | |
| Pubmed | The innate immune kinase TBK1 directly increases mTORC2 activity and downstream signaling to Akt. | 2.94e-05 | 2 | 189 | 2 | 34245780 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 21372221 | ||
| Interaction | LRRC31 interactions | ACACA ATR DSP CNTNAP1 PARP1 ANAPC1 MTOR AHNAK PLEC ASCC3 GCN1 CNOT1 | 4.20e-07 | 205 | 184 | 12 | int:LRRC31 |
| Interaction | SIRT7 interactions | FLNC ACACA ATR CENPF DSP DDX56 NOP14 ANAPC1 MTOR AHNAK MDC1 GEMIN4 PDCD11 PLEC ASCC3 GCN1 MVP HSPA2 UTRN CNOT1 STAG2 PTCD3 | 1.28e-06 | 744 | 184 | 22 | int:SIRT7 |
| Interaction | AGR2 interactions | FLNC ACACA DSP DYNC2H1 SPTA1 LARS1 SLC1A5 RYR1 CRMP1 DNAH1 SFXN1 PARP1 CPNE6 MTHFD1 SCD AHNAK PRPF19 PLEC CTSD GCN1 HSPA2 UTRN CNOT1 RIC3 | 4.67e-06 | 934 | 184 | 24 | int:AGR2 |
| Interaction | MCM2 interactions | HSPG2 FLNC ACACA RGPD8 ATR DSP ITSN1 RGPD1 MED14 SLC1A5 DNAH1 PARP1 CPNE6 MTHFD1 AHNAK TBK1 CSRP2 PLEC GCN1 MVP HSPA2 UTRN CNOT1 FKBP5 RGPD5 CDK6 | 5.95e-06 | 1081 | 184 | 26 | int:MCM2 |
| Interaction | EEF1AKMT3 interactions | EHBP1L1 ANAPC1 NBEAL2 TBK1 GEMIN4 CDK11B ASCC3 PATJ DSCC1 GCN1 HSPA2 FKBP5 RGPD5 CDK6 | 6.76e-06 | 364 | 184 | 14 | int:EEF1AKMT3 |
| Interaction | ERCC4 interactions | 9.28e-06 | 81 | 184 | 7 | int:ERCC4 | |
| Interaction | TOP3B interactions | PLXNA3 HSPG2 FLNC CRYBG2 DIRAS1 ACACA CENPF INPPL1 LARS1 MED14 DDX56 APOB SLC1A5 RYR1 EHBP1L1 FAM83F MTOR NAPRT NBEAL2 AHNAK MDC1 INTS11 MIB1 PDCD11 POLL GNAI3 PLEC GCN1 CNOT1 PREX1 PLXNA1 | 1.00e-05 | 1470 | 184 | 31 | int:TOP3B |
| Interaction | CD40 interactions | 1.17e-05 | 153 | 184 | 9 | int:CD40 | |
| Interaction | METTL14 interactions | FLNC ACACA DSP LARS1 CPS1 PDCD4 FBXO38 PARP1 AHNAK GEMIN4 GNAT3 GNAI3 PLEC CTSD GCN1 HSPA2 PTCD3 | 1.51e-05 | 558 | 184 | 17 | int:METTL14 |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq26 | CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 CT45A3 CT45A5 | 4.40e-08 | 171 | 189 | 9 | chrXq26 |
| Cytoband | Xq26.3 | 8.81e-06 | 67 | 189 | 5 | Xq26.3 | |
| GeneFamily | PDZ domain containing | 9.95e-05 | 152 | 127 | 7 | 1220 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 4.49e-04 | 51 | 127 | 4 | 870 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.33e-03 | 8 | 127 | 2 | 939 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 1.71e-03 | 9 | 127 | 2 | 1223 | |
| GeneFamily | Plexins | 1.71e-03 | 9 | 127 | 2 | 683 | |
| GeneFamily | WD repeat domain containing | 2.53e-03 | 262 | 127 | 7 | 362 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 2.58e-03 | 11 | 127 | 2 | 1168 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL | CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 DACH2 CT45A3 CT45A5 | 6.01e-11 | 69 | 186 | 10 | M45681 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL | CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 DACH2 CT45A3 CT45A5 | 3.72e-09 | 104 | 186 | 10 | M45682 |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | RARA ATR SLC36A4 AMACR INPPL1 MIER3 GPAT3 ANKMY1 PCMTD1 SLC1A4 PDCD4 NOP14 PTPRC PTPRE PIK3CA PDCD11 UGGT2 TRMT5 UTRN PREX1 GOLGB1 CDK6 | 1.02e-06 | 942 | 186 | 22 | M8144 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | ATR CENPF DYNC2H1 LARS1 SLC1A4 SLC1A5 FBXO38 ANAPC1 PIK3CA AHNAK UGGT2 GNAI3 PLEC ASCC3 TRMT5 CNOT1 CDK6 | 1.64e-05 | 721 | 186 | 17 | M10237 |
| Coexpression | RODRIGUES_DCC_TARGETS_DN | 2.32e-05 | 119 | 186 | 7 | M15927 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | RGPD8 MIER3 RGPD1 MED14 HELQ PTP4A1 DNAH1 IKBKE EPC1 ASCC3 PATJ RGPD5 PTCD3 | 3.68e-05 | 474 | 186 | 13 | M40991 |
| Coexpression | DAIRKEE_CANCER_PRONE_RESPONSE_E2 | 4.40e-05 | 28 | 186 | 4 | M6041 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 4.42e-05 | 289 | 186 | 10 | M2196 | |
| Coexpression | GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_DN | 6.45e-05 | 189 | 186 | 8 | M7555 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | FLNC PSAP FAT3 ITSN1 ACSS1 MPDZ JAM2 LIFR RGS6 C1orf226 SCD AHNAK PREX1 DIRAS2 | 6.56e-05 | 574 | 186 | 14 | M39056 |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | CT45A6 CT45A1 CT45A10 CT45A2 MPDZ CT45A9 ZNF33A DACH2 CT45A5 CDK11B ALDH2 | 1.75e-10 | 170 | 188 | 11 | fefb07a7e308b620f946b9ff2b01e1796446fe38 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 FAT3 SPTA1 APOB CPS1 PKHD1L1 DNAH1 ZFHX4 PKHD1 MYOM2 EPHA5 | 4.08e-10 | 184 | 188 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 FAT3 SPTA1 APOB CPS1 PKHD1L1 DNAH1 ZFHX4 PKHD1 MYOM2 EPHA5 | 4.08e-10 | 184 | 188 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 FAT3 SPTA1 APOB CPS1 PKHD1L1 DNAH1 ZFHX4 PKHD1 MYOM2 EPHA5 | 4.08e-10 | 184 | 188 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.23e-07 | 190 | 188 | 9 | d24af6af3271e34afab744352afd28be8a7cc5c3 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_monocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.23e-07 | 190 | 188 | 9 | 00ef6ec71353e42260c0d807d7da65b63154c288 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.40e-07 | 193 | 188 | 9 | 1db487e5f81849740d57cc3e2b5739e8f7581efb | |
| ToppCell | PBMC-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 1.82e-07 | 199 | 188 | 9 | ebf03979ef56e978d72db475bb635b43b9cbe402 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.60e-07 | 157 | 188 | 8 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.55e-07 | 176 | 188 | 8 | 6548797336c9f4ca0f38e74a2c629e2a4defa252 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.52e-06 | 190 | 188 | 8 | 71a00f63fdd4eb4cc6f190d37e7a0417cdaafacb | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.52e-06 | 190 | 188 | 8 | 18c020ca9a23399214133ec255ab870e0060f2e1 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.71e-06 | 193 | 188 | 8 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.78e-06 | 194 | 188 | 8 | a94f9f7179a5733e3c378ff8b337e288785433a1 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-classical_monocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.99e-06 | 197 | 188 | 8 | 5a81796c813bab9f8b7aedfd5e3a6a58c257837b | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.07e-06 | 198 | 188 | 8 | 74591eba5dbb2d77d416309326a26be969e4ad42 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.07e-06 | 198 | 188 | 8 | 3e1e79bb7b13540a06956b59c6a62984efea19ee | |
| ToppCell | mild_COVID-19_(asymptomatic)-Classical_Monocyte|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.15e-06 | 199 | 188 | 8 | 73a98d19871ffbc3c631de330998d42e9afa6da2 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.41e-06 | 160 | 188 | 7 | 5cd4fbbd2ce671a8377416eff94041a111375dee | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.05e-06 | 170 | 188 | 7 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.05e-06 | 170 | 188 | 7 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.02e-06 | 173 | 188 | 7 | 279efbab7810fa60ab12ea5d09a84800df4adef0 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.73e-06 | 175 | 188 | 7 | 89bf89466191da14896ed8928027f5b911436c22 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.01e-05 | 176 | 188 | 7 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 177 | 188 | 7 | dba8b30a311051c22ca5f77697f5dbf9423c3ba0 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 177 | 188 | 7 | 6561794ae3b14b5279b249eb5e93b80ef15ed82c | |
| ToppCell | Mid-temporal_gyrus_(MTG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-05 | 178 | 188 | 7 | ad187db4c40b9078d54dd915c143e0172b2f47b8 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-05 | 184 | 188 | 7 | 8e5fc2bdd3071e782aa8c56b8a39f8ea8f03f623 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.35e-05 | 184 | 188 | 7 | bc0dfe29337f02594e7e0092c9e47dda94b45ad5 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 185 | 188 | 7 | 53a5218c1e6eb12daccde3d6e02f337e2586d74c | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.44e-05 | 186 | 188 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.55e-05 | 188 | 188 | 7 | 116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 189 | 188 | 7 | 287e59104687fe1665232c52993889f0f2c97f17 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.60e-05 | 189 | 188 | 7 | 55aba1ebc012006a5db3ff9c92589cb3d9f7c68a | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 1.83e-05 | 193 | 188 | 7 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-05 | 193 | 188 | 7 | 4fb020f11fd7aff06952bfeaabc79b2c7b8873f6 | |
| ToppCell | normal_Lung|World / Location, Cell class and cell subclass | 1.89e-05 | 194 | 188 | 7 | affae83d7f982d18117f5b95705f09809f304b0b | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.89e-05 | 194 | 188 | 7 | 885355ebe98e974f841cc59dce3b5228c642c5d0 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-05 | 195 | 188 | 7 | 83d45ff5e5bc704448431149fffb2e4c1278f279 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-05 | 195 | 188 | 7 | fc75f04eb475c8139cc5c35e6be22e73fb2be9e6 | |
| ToppCell | Epithelial-Epithelial-A_(AT1)|Epithelial / shred on cell class and cell subclass (v4) | 2.02e-05 | 196 | 188 | 7 | 41b21a18125cc95bc8adde3369e4abd029cf137d | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-05 | 196 | 188 | 7 | a31e227de2dc077b81881295b012d22fedbd65ed | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-05 | 196 | 188 | 7 | b04ca69b0ed44e09c989b575f747e1e819cd8008 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.09e-05 | 197 | 188 | 7 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | normal-na-Myeloid-classical_monocyte-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.09e-05 | 197 | 188 | 7 | dc53d1c0d226ca22291a489c38e08a7ccdc3aeeb | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.09e-05 | 197 | 188 | 7 | 9c8c1ce8ed69b3c2b12ecca349ac1901f66b46ab | |
| ToppCell | normal-na-Myeloid-classical_monocyte|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.09e-05 | 197 | 188 | 7 | b98ceb82fe2126bbeb2df87a7243be0f2c0ccfa8 | |
| ToppCell | normal-na-Myeloid-classical_monocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.16e-05 | 198 | 188 | 7 | 58aa5041077fe17ca01c5e6da077d8008d5123ab | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.16e-05 | 198 | 188 | 7 | 45c6c1156ee41db051b873022a8a074f5730e95a | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.16e-05 | 198 | 188 | 7 | d347462ba6cb1c5a59c86dffbbe914cbc1e9cf16 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.16e-05 | 198 | 188 | 7 | c79c1738560d78b63dbed5f2f9621dbc1c2363cb | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.16e-05 | 198 | 188 | 7 | c5a22846bccff948f90bc1d5fe309907dcd08348 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.16e-05 | 198 | 188 | 7 | 1d1c80569f1e307285ba0ebaf5c72e0b5b538864 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.16e-05 | 198 | 188 | 7 | c49c71b34151d82b8795763bcb633c301c35f659 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.16e-05 | 198 | 188 | 7 | f3346c26b9647a199faf3cd7ab19c3a963dbabc2 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.16e-05 | 198 | 188 | 7 | 4780f0276546962a2fc9f1041cfe49d2919d72b2 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.16e-05 | 198 | 188 | 7 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | COVID-19_Mild-Myeloid-Classical_Monocyte|COVID-19_Mild / Disease group, lineage and cell class | 2.16e-05 | 198 | 188 | 7 | e78d027a095473af555762a4d542a73f5bb2e166 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.16e-05 | 198 | 188 | 7 | a85894aa7899e2732a3cf4cbfadc5ca395cbcacf | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.23e-05 | 199 | 188 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.23e-05 | 199 | 188 | 7 | 5ceeed92f831d068ff4bb3994f420002338330e7 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.23e-05 | 199 | 188 | 7 | 624d01e1f687b8116d113e910e6010c6ecdc1c01 | |
| ToppCell | RA-15._Ventricular_Cardiomyocyte_III|RA / Chamber and Cluster_Paper | 2.26e-05 | 134 | 188 | 6 | 60ee3accc54108e5b9a0018f6aa8488dc39d5ade | |
| ToppCell | COVID_vent-Myeloid|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.30e-05 | 200 | 188 | 7 | 621af09aae34226902c03edf556562f3ab35a7d8 | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.30e-05 | 200 | 188 | 7 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.30e-05 | 200 | 188 | 7 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | COVID_vent-Myeloid-Monocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.30e-05 | 200 | 188 | 7 | b0a5bee87700ce38f26f95a6f491da7e27cade51 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-CD14+_Monocyte|COVID-19_Mild / Disease, condition lineage and cell class | 2.30e-05 | 200 | 188 | 7 | f76d3647f8ab5f7be018b0697c911597198e03f5 | |
| ToppCell | Influenza|World / Disease, condition lineage and cell class | 2.30e-05 | 200 | 188 | 7 | df996c35907a1c9194b9e2ca30e81f520ca067f0 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD14+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.30e-05 | 200 | 188 | 7 | e57452b73abb21cb3f645d45523ab93f6bef0243 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.31e-05 | 156 | 188 | 6 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.31e-05 | 156 | 188 | 6 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.50e-05 | 157 | 188 | 6 | 8c42af7aa1f1b6f4fe2f8d00a8b4a800f121e804 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.50e-05 | 157 | 188 | 6 | ee1be3c756b72fceac6b4ccb416dd4bd031a2193 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.50e-05 | 157 | 188 | 6 | 008f938a338f43c3251dcac574f1b4f689926c71 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 160 | 188 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | Control-CD8+_T|World / Disease group and Cell class | 6.11e-05 | 160 | 188 | 6 | f5151f5cf1a4a4a997496e03e48293e4c751d077 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 160 | 188 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.11e-05 | 160 | 188 | 6 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.55e-05 | 162 | 188 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 162 | 188 | 6 | 2ac02523348660e514d464f8f2434ee0c312d784 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 162 | 188 | 6 | 6972d45f4bd4b6522bf93295f7e9dca7c6cba1f3 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-05 | 165 | 188 | 6 | 02a09d0918b103aca21c36b42c5a8a8ebad8686c | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-05 | 165 | 188 | 6 | 906321cb5f299d77436fb5540fd8c52d7532beca | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-05 | 167 | 188 | 6 | ed7e785dcd25777f64e0c2596ada4f5a5ea17121 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-05 | 168 | 188 | 6 | 35ce3b2b9c9997d4c101da5949c7271d6a6b8f12 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 169 | 188 | 6 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 169 | 188 | 6 | f00741203efa0b948db7223ee8c19bdd0918258a | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 169 | 188 | 6 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.54e-05 | 170 | 188 | 6 | 985c2d5962100fab0d95bee39f382ccbe799331e | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.54e-05 | 170 | 188 | 6 | dd48fd3c5c67eb71183981f42975a538f12077c3 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.11e-05 | 172 | 188 | 6 | 584af6537685cb459bf0fc298e6f46872016c116 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.00e-04 | 175 | 188 | 6 | 35fb7735dd3355476fe60404833cb60bd066bcf1 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.00e-04 | 175 | 188 | 6 | 442f261a3b2c4d2523f7d4089178f8c79cac2f0f | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.07e-04 | 177 | 188 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 177 | 188 | 6 | f6b9d91d46830d0d207b0abd4ee5a4942fd99774 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-04 | 177 | 188 | 6 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-04 | 178 | 188 | 6 | 76e71fff99cf64302e2e3c0d66dd8ba0ff13624e | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-04 | 178 | 188 | 6 | 82f78ea1ea3ff3e2347cd8bc2f06e2a10e96f220 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-04 | 178 | 188 | 6 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| Disease | Alzheimer disease, dementia, family history of Alzheimer’s disease | 8.63e-06 | 48 | 171 | 5 | EFO_0009268, MONDO_0001627, MONDO_0004975 | |
| Disease | total blood protein measurement | DNAH3 ITGA1 CPS1 DNAH1 PARP1 PTPN3 EHBP1L1 IKBKE PKHD1 ACSF3 ASCC3 CDK6 | 1.32e-05 | 449 | 171 | 12 | EFO_0004536 |
| Disease | Colorectal Carcinoma | FLNC DNAH3 RARB ACACA AMACR RBP3 APOB SFXN1 LIFR PARP1 CORO2B PIK3CA PKHD1 ALDH2 RIC3 | 1.58e-05 | 702 | 171 | 15 | C0009402 |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 2.60e-05 | 60 | 171 | 5 | EFO_0020690 | |
| Disease | Malonic aciduria | 3.34e-05 | 2 | 171 | 2 | C0342793 | |
| Disease | angina pectoris | 9.21e-05 | 125 | 171 | 6 | EFO_0003913 | |
| Disease | indolepropionylglycine measurement | 9.98e-05 | 3 | 171 | 2 | EFO_0800089 | |
| Disease | Schwartz-Jampel syndrome | 9.98e-05 | 3 | 171 | 2 | cv:C0036391 | |
| Disease | secretogranin-3 measurement | 9.98e-05 | 3 | 171 | 2 | EFO_0802042 | |
| Disease | Neuralgia-Neuritis, Sciatic Nerve | 1.99e-04 | 4 | 171 | 2 | C0751924 | |
| Disease | Sciatic Nerve Palsy | 1.99e-04 | 4 | 171 | 2 | C0751925 | |
| Disease | Sciatic Neuropathy | 1.99e-04 | 4 | 171 | 2 | C0149940 | |
| Disease | Lesion of Sciatic Nerve | 1.99e-04 | 4 | 171 | 2 | C0154748 | |
| Disease | Sciatic Neuritis | 1.99e-04 | 4 | 171 | 2 | C0242013 | |
| Disease | Congenital myotonia | 1.99e-04 | 4 | 171 | 2 | cv:CN295225 | |
| Disease | Intellectual Disability | 2.97e-04 | 447 | 171 | 10 | C3714756 | |
| Disease | 2-butenoylglycine measurement | 3.30e-04 | 5 | 171 | 2 | EFO_0800556 | |
| Disease | 3-hydroxybutyroylglycine measurement | 3.30e-04 | 5 | 171 | 2 | EFO_0800568 | |
| Disease | galectin-7 measurement | 4.93e-04 | 6 | 171 | 2 | EFO_0022034 | |
| Disease | Hemimegalencephaly | 4.93e-04 | 6 | 171 | 2 | C0431391 | |
| Disease | episodic ataxia type 6 (implicated_via_orthology) | 4.93e-04 | 6 | 171 | 2 | DOID:0050994 (implicated_via_orthology) | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 5.60e-04 | 65 | 171 | 4 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | red blood cell density measurement | ATR SPTA1 ITSN1 ITGA1 CPS1 ZFPM2 PTPN3 PTPRC PIK3CA PKHD1 PLEC ACMSD PREX1 CDK6 | 6.42e-04 | 880 | 171 | 14 | EFO_0007978 |
| Disease | hexanoylglycine measurement | 6.88e-04 | 7 | 171 | 2 | EFO_0800233 | |
| Disease | gamma-glutamylglycine measurement | 6.88e-04 | 7 | 171 | 2 | EFO_0800670 | |
| Disease | mean reticulocyte volume | ATR SGCG SPTA1 ITSN1 FBXO38 PTPRC PIK3CA MTOR ACSF3 PREX1 STAG2 GOLGB1 CDK6 | 8.16e-04 | 799 | 171 | 13 | EFO_0010701 |
| Disease | Large cell carcinoma of lung | 8.38e-04 | 32 | 171 | 3 | C0345958 | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 9.14e-04 | 8 | 171 | 2 | DOID:1858 (implicated_via_orthology) | |
| Disease | holoprosencephaly (is_implicated_in) | 9.14e-04 | 8 | 171 | 2 | DOID:4621 (is_implicated_in) | |
| Disease | glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) measurement | 9.14e-04 | 8 | 171 | 2 | EFO_0800533 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 9.18e-04 | 128 | 171 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 9.18e-04 | 128 | 171 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 9.18e-04 | 128 | 171 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 9.18e-04 | 128 | 171 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 9.18e-04 | 128 | 171 | 5 | C0007134 | |
| Disease | Prostatic Neoplasms | ATR CENPF AMACR CYP3A43 ITSN1 LIFR PARP1 PTPRC PIK3CA PATJ CTSD | 9.80e-04 | 616 | 171 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | ATR CENPF AMACR CYP3A43 ITSN1 LIFR PARP1 PTPRC PIK3CA PATJ CTSD | 9.80e-04 | 616 | 171 | 11 | C0376358 |
| Disease | Vasodilators used in cardiac diseases use measurement | 1.00e-03 | 34 | 171 | 3 | EFO_0009926 | |
| Disease | neuropsychological test | 1.05e-03 | 197 | 171 | 6 | EFO_0003926 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.25e-03 | 447 | 171 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.32e-03 | 206 | 171 | 6 | C0152013 | |
| Disease | neuroimaging measurement, brain volume measurement | 1.45e-03 | 286 | 171 | 7 | EFO_0004346, EFO_0006930 | |
| Disease | Malignant neoplasm of breast | RARA RARB ACADM CENPF DYNC2H1 ARHGEF38 MED14 HELQ PDCD4 PARP1 PTPRC FAM83F PIK3CA MTOR GOLGB1 | 1.53e-03 | 1074 | 171 | 15 | C0006142 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.75e-03 | 148 | 171 | 5 | C0279702 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 1.77e-03 | 11 | 171 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | lymphocyte count | ACACA SPTA1 EML6 WDR27 ITGA1 CPS1 ZFPM2 PTPRC IKBKE ANAPC1 MTHFD1 AHNAK PLEC DDHD2 ATP1B3 PREX1 FKBP5 CDK6 | 2.17e-03 | 1464 | 171 | 18 | EFO_0004587 |
| Disease | economic and social preference | 2.48e-03 | 97 | 171 | 4 | EFO_0004827 | |
| Disease | tetralogy of Fallot (is_implicated_in) | 2.50e-03 | 13 | 171 | 2 | DOID:6419 (is_implicated_in) | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 2.50e-03 | 13 | 171 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | glutaroyl carnitine measurement | 2.50e-03 | 13 | 171 | 2 | EFO_0021005 | |
| Disease | Malformations of Cortical Development | 2.90e-03 | 14 | 171 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 2.90e-03 | 14 | 171 | 2 | C0431380 | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 2.90e-03 | 14 | 171 | 2 | cv:C2931907 | |
| Disease | Duchenne muscular dystrophy, disease progression measurement | 3.07e-03 | 50 | 171 | 3 | EFO_0008336, MONDO_0010679 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 3.27e-03 | 171 | 171 | 5 | DOID:9352 (is_implicated_in) | |
| Disease | retinal vasculature measurement | 3.32e-03 | 517 | 171 | 9 | EFO_0010554 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 3.34e-03 | 15 | 171 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 3.34e-03 | 15 | 171 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 3.34e-03 | 15 | 171 | 2 | C0154091 | |
| Disease | platelet crit | DNAH3 ZNF407 APOB CPS1 NHP2 ZFPM2 MLYCD PARP1 PTPRC ALDH2 PLEC PREX1 CDK6 | 3.78e-03 | 952 | 171 | 13 | EFO_0007985 |
| Disease | cystatin-F measurement | 3.80e-03 | 16 | 171 | 2 | EFO_0008104 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 3.80e-03 | 16 | 171 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | Glioblastoma Multiforme | 4.03e-03 | 111 | 171 | 4 | C1621958 | |
| Disease | tonsillectomy risk measurement | 4.19e-03 | 260 | 171 | 6 | EFO_0007924 | |
| Disease | heel bone mineral density, urate measurement | 4.26e-03 | 182 | 171 | 5 | EFO_0004531, EFO_0009270 | |
| Disease | Benign neoplasm of stomach | 4.29e-03 | 17 | 171 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 4.29e-03 | 17 | 171 | 2 | C0496905 | |
| Disease | Necrotizing Enterocolitis | 4.29e-03 | 17 | 171 | 2 | C0520459 | |
| Disease | Carcinoma in situ of stomach | 4.29e-03 | 17 | 171 | 2 | C0154060 | |
| Disease | myocardial infarction | 4.45e-03 | 350 | 171 | 7 | EFO_0000612 | |
| Disease | Carcinoma of bladder | 4.81e-03 | 18 | 171 | 2 | C0699885 | |
| Disease | Alcoholic Intoxication, Chronic | 4.85e-03 | 268 | 171 | 6 | C0001973 | |
| Disease | Lipoidosis | 5.35e-03 | 19 | 171 | 2 | C0023794 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 5.35e-03 | 19 | 171 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Chronic myeloproliferative disorder | 5.35e-03 | 19 | 171 | 2 | C1292778 | |
| Disease | creatinine measurement | RARB CENPF DPYSL5 CPS1 RYR1 CRMP1 PTPN3 PKHD1 PNPLA7 PLEC ASCC3 RNF128 RIC3 | 5.44e-03 | 995 | 171 | 13 | EFO_0004518 |
| Disease | metabolite measurement | 5.56e-03 | 560 | 171 | 9 | EFO_0004725 | |
| Disease | Liver Cirrhosis, Experimental | AMACR INPPL1 SRR CPS1 ACOX2 BLVRA PTPRC ASAH1 AHNAK ALDH2 MVP | 5.65e-03 | 774 | 171 | 11 | C0023893 |
| Disease | vital capacity | HSPG2 RARB DSP FSIP1 WDR27 APOB PRDM11 NOP14 ALDH2 PATJ UTRN FKBP5 PLXNA1 PDZD2 CDK6 | 5.68e-03 | 1236 | 171 | 15 | EFO_0004312 |
| Disease | Colorectal Neoplasms | 5.68e-03 | 277 | 171 | 6 | C0009404 | |
| Disease | pursuit maintenance gain measurement | 5.79e-03 | 123 | 171 | 4 | EFO_0008433 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EMIDRLEKGSGQQPV | 141 | Q9H2F5 | |
| IIIGDIGPKMDFDQT | 236 | Q99424 | |
| TRVKVPVGQEVEGMN | 216 | Q15758 | |
| IVPVLMDEKGSVVEG | 476 | Q9NUB1 | |
| GQRVEEVPGDLMAKR | 71 | Q5SNV9 | |
| GRVMETGVIDPEIQR | 1186 | P78357 | |
| GIPVIKEGILDAIMV | 396 | Q6P2P2 | |
| VLDGEGRTPLMKALQ | 101 | Q9BXX2 | |
| RRGVMEKLQLGPEIL | 81 | Q9UHK6 | |
| KLGVIPNVEGRVMDV | 376 | P22570 | |
| MQVIGEVFLQIKGPL | 166 | Q9NXL2 | |
| RVMKLNTEVRDVGPL | 191 | P54756 | |
| VVILNMPKGTEFGID | 21 | Q9Y312 | |
| VGLSEMAQKNVGVRP | 111 | Q8NB90 | |
| EMLEGVQGPTAVRKR | 146 | P0DMU8 | |
| DTPGRMQEKGVISDI | 2191 | Q13085 | |
| PEVRIREMDQKGVTV | 56 | Q8TDX5 | |
| KIEGEMQVPDVDIRG | 1091 | Q09666 | |
| VLVEEIPRNQMGKID | 551 | Q4G176 | |
| ALKRVRVQTGEEGMP | 41 | Q00534 | |
| MKGIAAVTDIPLGEI | 116 | Q13510 | |
| PGEVKTLMIQLLRGV | 536 | P21127 | |
| VGAGPAILRNKAMLE | 2581 | Q8TDJ6 | |
| ADTPGIQIGRKELNM | 226 | P11310 | |
| GLRMLKDTGIPDIEI | 556 | Q96NX9 | |
| EMLEGVQGPTAVRKR | 146 | P0DMV0 | |
| SIPGIGKRMAEKIIE | 301 | Q9UGP5 | |
| RLPMSIIIVGVGNAD | 461 | O95741 | |
| MVVAGKLQDRGPDVL | 491 | Q14624 | |
| QGVPAVGVMKELVER | 51 | Q5RL73 | |
| DGLLVMRKIENVPTG | 146 | O43447 | |
| KQVEVIVDTGAMAPG | 3196 | P98160 | |
| GAERVITLKMEIPGS | 391 | P10276 | |
| GAERVITLKMEIPGS | 391 | P10826 | |
| TVPIMLVGNKADIRD | 646 | Q8IZ41 | |
| VQMPEKVELVTGEEG | 1041 | Q99666 | |
| VQMPEKVELVTGEEG | 1041 | O14715 | |
| MQDDKTGGVPIRTVK | 36 | P49758 | |
| KGGVDQKMPLVVSRI | 526 | P26045 | |
| RVGTVIGSNKLEQMP | 591 | P09874 | |
| PVEKIDTMLVLEGSG | 481 | Q9H1A4 | |
| IVKRVGNGEETPMIG | 36 | Q13451 | |
| VGRNIPVTLIDMDKA | 356 | Q9NXN4 | |
| SPALQVLREMKAIGI | 351 | Q96EY7 | |
| PAEGKGMIDLIAAVQ | 601 | P23469 | |
| PGMTVAEKLRVAALV | 236 | Q96G91 | |
| DGGMTPQLAEVIKRL | 116 | A8MTJ3 | |
| GDNQVMPKTGLLIIV | 191 | P43356 | |
| GRQTVDKVMGIPKET | 806 | Q14676 | |
| PILGLIFLMGNRVKE | 406 | Q8TD90 | |
| EGVMTPELAGVIKRL | 116 | P08754 | |
| KGIMQLVGQAEPESV | 396 | Q5TA45 | |
| GQMERGKVVLETPRN | 366 | Q86W26 | |
| EMLEGVQGPTAVRKR | 146 | P0DMU9 | |
| MVIVNGGLKQDERPA | 1041 | Q8WW38 | |
| IKPGNIMRLVGEEGQ | 136 | Q14164 | |
| SQRAVLMEKPDVVVG | 126 | Q9NY93 | |
| ALKLVEGPDVREMNG | 166 | O95822 | |
| IETAGGVMTPLIKRN | 406 | P54652 | |
| LKVGGILVMPIEDQL | 181 | Q96MG8 | |
| LNLGEMKSGVPVLAV | 191 | Q53EL6 | |
| QMEKGPIDAITGEAR | 1471 | Q9UIW2 | |
| QMEKGPIDAITGEAR | 1446 | P51805 | |
| VMEVTLNKEPRVGLG | 726 | O15018 | |
| PDGFKQIRQGMITLI | 406 | O76083 | |
| EMLEGVQGPTAVRKR | 146 | Q8NHU0 | |
| FAVQKGELTGEVRMP | 1791 | Q14315 | |
| VKEEVLPINVGMLNG | 641 | O94830 | |
| GPLKIEDTIQSEMLG | 686 | Q8N3D4 | |
| TEPLVLKSGNRIVMG | 576 | O43896 | |
| ETLVPKAEGDRVMVV | 411 | Q92917 | |
| KAEGDRVMVVLGPQT | 416 | Q92917 | |
| LVPAIKEDAGGMIQR | 1366 | Q92616 | |
| PGKRMQVDDLNISGI | 226 | P57087 | |
| MEKLINRVGPNGESR | 161 | Q7Z5B4 | |
| GNSPEDLRKEIMIGL | 166 | Q7Z3K6 | |
| LLERMDIGPKQTQVG | 196 | P56199 | |
| MIETKGRAALPGLDV | 531 | P78316 | |
| TIRDLAVAGPEMQVK | 806 | Q14764 | |
| EMVGQLAVLTGEPLI | 526 | Q6ZV29 | |
| KILNREIGFAIGMPV | 111 | P42336 | |
| NLLSEPVGGRKVVEM | 751 | O60244 | |
| AMLPTLGKVGRVQQI | 361 | Q86YT6 | |
| LEIGFNLVIVPKMLG | 56 | Q9H208 | |
| EIGFNLVIVPKMLGT | 71 | Q9H209 | |
| DLGELVGMTPEIIQK | 161 | Q9UMS4 | |
| VENPGIITDIGMKAV | 381 | Q6PIJ6 | |
| QIKGSVEDIPVMLVG | 106 | O95057 | |
| MKGIPERLVGLEERI | 871 | Q9P2D7 | |
| GKTLIIQEMDGVEPV | 3321 | Q8NCM8 | |
| LQGIPQMIGEVIRKG | 806 | P04114 | |
| GLKNPVIEMLEGIAV | 481 | Q13535 | |
| NGVKIMGTSPLQIDR | 1071 | P31327 | |
| EMLEGVQGPTAVRKR | 146 | Q5HYN5 | |
| EMLEGVQGPTAVRKR | 146 | P0DMV2 | |
| GIFQMIIAGREPKET | 506 | A0AVF1 | |
| VPEGMVTSLDQLKGL | 296 | Q9BVC3 | |
| EIPEGGLKRNMTEAL | 116 | Q9UQ03 | |
| IEINGVFIPKGLAVM | 381 | Q9HB55 | |
| NMDRGERLGIKPESV | 81 | Q16527 | |
| VKEMQLGLEEGLVPS | 1461 | P49454 | |
| DIIAQMPEEGRKFGI | 1101 | Q8TD57 | |
| IIQRDESPMEKGLSG | 71 | Q53EU6 | |
| MEREERGKVLPNGEV | 181 | A1L170 | |
| EIKGDVESIPIMLVG | 106 | Q96HU8 | |
| EGKLIPGDQIVMIND | 111 | Q14CM0 | |
| MVGPVDEVRELQKAI | 301 | P07339 | |
| EMLEGVQGPTAVRKR | 146 | Q5DJT8 | |
| EAMKIGLVRPGTALE | 2276 | P15924 | |
| SLKVEGMVAIVQLGP | 316 | Q96SY0 | |
| GRLMVNVVEGIELKP | 1596 | Q15811 | |
| GQKLVLPEGDMELRT | 1036 | Q8N1P7 | |
| GMPVGTKLTQVRAID | 2826 | Q8TDW7 | |
| KPVMLRQGEKEAVGT | 766 | Q9P2S6 | |
| VVQGIIERVKMDLNP | 91 | A6NIL9 | |
| MNAEPERKFGVVVVG | 1 | P53004 | |
| EMLEGVQGPTAVRKR | 146 | P0DMV1 | |
| GERNMEVTPGEKILR | 356 | Q8NA03 | |
| LEIDKSGPMTLLVQG | 981 | Q6ZMW3 | |
| IPLMEVTGVLEGRAK | 1011 | Q8TDG4 | |
| GLEEGLLQMKLPESV | 1921 | P21817 | |
| KGIMVLAGDTLPIEV | 76 | Q9NX24 | |
| ILVVATGQPEMVKGE | 211 | P11586 | |
| GPKLLAETADMIGVR | 141 | Q9NPB3 | |
| EMLEGVQGPTAVRKR | 146 | P0DMU7 | |
| VPGGVKTIEANGRMV | 51 | Q14194 | |
| AQEQKRILEMGITGP | 206 | Q14194 | |
| QQVGRELMIPGGAKV | 36 | Q9BPU6 | |
| IPNDDLKIEQVVGMG | 626 | P42702 | |
| VLRALKESGAGMPEQ | 31 | Q3SYA9 | |
| EIGFNLVIVPKMLGT | 71 | Q9H207 | |
| VQMPEKVELVTGEEG | 1026 | P0DJD0 | |
| RAMGPGIQQDIKELL | 491 | P42345 | |
| MKEIETNLRSGPVAG | 1076 | P46939 | |
| QGPVKEELMQLLGLS | 361 | Q32P41 | |
| LFLIGQGMEKPEIID | 286 | Q9BZE2 | |
| MRQRELKVGIPVTDE | 196 | Q9H9B4 | |
| VPVVKELMGEEILGA | 346 | Q9P2J5 | |
| QGLVLPLGKSSEERM | 931 | Q6ZNJ1 | |
| DRAALTIPQGMEVVK | 141 | Q9NQV5 | |
| ATDIMRKQGPRVEIL | 1616 | Q8TCU6 | |
| PGAVDIVAIMIGNLK | 161 | Q8TEB7 | |
| EETGNIRGSMKVRVP | 861 | O15357 | |
| EGQVQVILRVKEGMP | 2706 | P08F94 | |
| GGPVDLIKIRLQMQT | 121 | Q6ZT89 | |
| ERMKLLIEPTAGVGV | 276 | Q9GZT4 | |
| IPLGELSQKDGRMVS | 391 | Q8NEG4 | |
| GGPNQDLTVLEMKRE | 551 | Q13438 | |
| EVTGRLKVGPKMVEV | 121 | Q13326 | |
| RVTLELGGKSPNIIM | 281 | P05091 | |
| VGLVLMEGVTDTKPE | 526 | Q9UNK9 | |
| PLGIIVKELTGDMQL | 556 | Q8N3C0 | |
| ILVKMNRIIGLKPEG | 171 | P54709 | |
| IQRGLGMEVFPVDLI | 381 | A5YKK6 | |
| ERMPEQIRLKVGGVD | 1551 | A5YKK6 | |
| EVAMGRVVKVTPNEG | 1231 | Q14690 | |
| KVVMNTDLGVGPIRD | 81 | Q9Y5R8 | |
| LQGDLTKQLPIMVVG | 871 | O94967 | |
| MLGNEIGLPKRVVQV | 2916 | Q86UP3 | |
| QTLREGEKMQLPAGE | 571 | P38435 | |
| MAELETVKAVGPQLV | 751 | P10745 | |
| EIQGLRTVEMKKGPT | 1856 | O75970 | |
| PGTLIKDIRENGMKV | 101 | Q2QD12 | |
| RGMPETLGQVAKALE | 76 | Q6NXR4 | |
| GPRMTLQLIKVQEGV | 276 | Q9NQ55 | |
| LKTGIENGDMPEQIV | 716 | Q8N3U4 | |
| VPGQEMIIEISKGRS | 1431 | Q8NI35 | |
| KIPIGTEIEGMNILG | 211 | P43007 | |
| GPVKGQILMRLVEEK | 116 | Q8WZ04 | |
| EVRLTMLPQVGKDGV | 1346 | O94964 | |
| MLGPVGIEAVLDQLK | 26 | Q8IYM1 | |
| MAQGLIEVERKFLPG | 1 | Q9BU02 | |
| MGRVTNPDTQEIKGR | 386 | O75830 | |
| KLVAVGGQPRMKLTE | 396 | Q6XQN6 | |
| MEDGPIVKLASNLGV | 506 | Q9NW08 | |
| RVLQNGGDKLETMPL | 26 | O00767 | |
| EPRIQEITERGNKMV | 846 | P02549 | |
| KRSMGFIIEIEIGDP | 3986 | Q86WI1 | |
| KLTVEEAVRMGIVGP | 4121 | Q15149 | |
| VILDIIKGEMSRPGE | 116 | P07602 | |
| EMLTKEQGDVIGIPF | 111 | Q06730 | |
| EIMPSVAEGIKIGIQ | 61 | P56704 | |
| GVQEDPVLGNKEILM | 1296 | Q9C0G0 | |
| EKVLQGLVPRGTVMG | 106 | A2RRH5 | |
| QDVLKLRPGEMGIVS | 861 | Q9NYU1 | |
| PKMEIRVVTLGLDGA | 401 | P36406 | |
| QPGTLLDLLQVEGMK | 96 | A5D8V6 | |
| VMIAAQGPLKETIGD | 1031 | P08575 | |
| APVLVALALIEGGMK | 111 | Q93096 | |
| GIGVVLPLENQMKES | 286 | Q6YBV0 | |
| IKPGNIMRVIGEDGQ | 136 | Q9UHD2 | |
| EAPVFLMILLKGGEQ | 61 | A0A087WSZ9 | |
| LRDVILVLMEGTPKG | 221 | Q9BRI3 | |
| GIGPEERRQTLLQKM | 1041 | P57678 | |
| IEEMKAQGGTVLPTE | 111 | Q14789 | |
| LIGGLPDVVTIMEGK | 1346 | P54296 |